Linden Advisors’s CERo Therapeutics Holdings, Inc. Warrants CEROW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.73K | Hold |
249,999
| – | – | ﹤0.01% | 372 |
|
|
2025
Q1 | $3.33K | Hold |
249,999
| – | – | ﹤0.01% | 303 |
|
|
2024
Q4 | $2.3K | Hold |
249,999
| – | – | ﹤0.01% | 261 |
|
|
2024
Q3 | $1.48K | Hold |
249,999
| – | – | ﹤0.01% | 276 |
|
|
2024
Q2 | $5.63K | Hold |
249,999
| – | – | ﹤0.01% | 278 |
|
|
2024
Q1 | $20K | Hold |
249,999
| – | – | ﹤0.01% | 265 |
|
|
2023
Q4 | $6.88K | Hold |
249,999
| – | – | ﹤0.01% | 302 |
|
|
2023
Q3 | $19.2K | Hold |
249,999
| – | – | ﹤0.01% | 305 |
|
|
2023
Q2 | $16.4K | Hold |
249,999
| – | – | ﹤0.01% | 331 |
|
|
2023
Q1 | $10K | Hold |
249,999
| – | – | ﹤0.01% | 431 |
|
|
2022
Q4 | $12.6K | Hold |
249,999
| – | – | ﹤0.01% | 484 |
|
|
2022
Q3 | $27K | Hold |
249,999
| – | – | ﹤0.01% | 567 |
|
|
2022
Q2 | $27K | Hold |
249,999
| – | – | ﹤0.01% | 637 |
|
|
2022
Q1 | $55K | Buy |
+249,999
| New | +$55K | ﹤0.01% | 650 |
|